Comparison of Serum Salicylate Levels and Gastro-Intestinal Blood Loss Between Salsalate (Disalcid) and other Forms of Salicylates
- 1 January 1981
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 10 (3) , 169-173
- https://doi.org/10.3109/03009748109095292
Abstract
In a first stage the effect of a single dose of 3 g of salsalate on serum salicylate level was compared with a single intake of 3 g of soluble or enteric-coated acetylsalicylates in 12 healthy subjects. Salsalate seems to resorb faster than the enteric-coated forms but more slowly than the soluble forms of acetylsalicylate. However, in comparison with these latter forms, salsalate activity is more protracted. In the second part of the study, 42 patients were admitted to a trial in which 3 to 5 g of salsalate was given daily and in which serum salicylate levels and blood loss in stools were measured using the method of labelling red blood cells with Cr. The ideal dosage to obtain a serum salicylate level of 20 mg/100 ml seems to lie between 3 and 4 g of salsalate a day. Salsalate caused abnormal gastro-intestinal Mood loss in only 2 of the 42 patients studied, which is significantly fewer compared with the soluble, intravenous or enteric-coated forms of acetylsalicylates.This publication has 6 references indexed in Scilit:
- SALICYLATE-INDUCED GASTRO-INTESTINAL BLEEDING - COMPARISON BETWEEN SOLUBLE BUFFERED, ENTERIC-COATED, AND INTRAVENOUS ADMINISTRATION1979
- Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandinsProstaglandins, 1976
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975
- Gastric mucosa and susceptibility to occult gastrointestinal bleeding caused by aspirin.BMJ, 1967
- Carcinoid syndrome associated with hyperserotoninemia and normal 5-hydroxyindoleacetic acid excretionThe American Journal of Medicine, 1961